Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. - sprookjes - yvandenbroek - TriplyDB

Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube.

Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube.

http://www.wikidata.org/entity/Q33964412

about

Fecal transplantation for recurrent or refractory Clostridium difficile diarrhea Treating Clostridium difficile infection with fecal microbiota transplantation Bench-to-bedside review: Clostridium difficile colitis Fecal Microbiota Transplantation and Its Usage in Neuropsychiatric Disorders Recent Advances in the Diagnosis and Treatment of Clostridium Difficile Infection Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic Resistance Fecal microbiota transplantation: current clinical efficacy and future prospects Human microbiome: From the bathroom to the bedside Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease Defining dysbiosis and its influence on host immunity and disease Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook The potential for emerging therapeutic options for Clostridium difficile infection Fecal microbiota transplantation and emerging applications Fecal transplantation for recurrent Clostridium difficile infection in older adults: a review The challenges posed by reemerging Clostridium difficile infection.Clostridium difficile infection: New insights into therapeutic options.Clostridium difficile infection: guideline-based diagnosis and treatment [Current data and trends on the development of antibiotic resistance of Clostridium difficile].Relationship of symptom duration and fecal bacteriotherapy in Clostridium difficile infection-pooled data analysis and a systematic review.Moving fecal microbiota transplantation into the mainstream.Efficacy of oral fecal bacteriotherapy in rhesus macaques (Macaca mulatta) with chronic diarrhea.Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation.Fecal Microbiota Transplantation for Clostridium difficile Infection: The Ochsner Experience.Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study Clostridium difficile infection in older adults Recovery of the gut microbiome following fecal microbiota transplantation.Fecal transplantation for the treatment of Clostridium difficile infection.Experimental and analytical tools for studying the human microbiome.Clostridium difficile colitis: a review.American Journal of Gastroenterology Lecture: Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection.Recommendations for probiotic use in humans-a 2014 update Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series.Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective.Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis.Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea.Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond.

P2860

Q24234630-1ED78077-5D04-4F88-B67A-B93095B11072 Q24634294-3D936097-CD59-42B1-9C9C-2DF072CE47D2 Q24644191-A1709379-D813-4885-81F0-1C2E0CAD75C4 Q26739667-38D39A5F-A887-45D9-AC82-527960A22869 Q26766112-DF83246E-81A1-46AA-B643-6B7542AF467B Q26771287-863A3038-5C01-4E24-ADC0-13E12364A3CB Q26771995-ED6DE2DD-EBCA-46A6-8FE0-7412C2358990 Q26777245-91EA7261-320B-4E0E-87ED-046377AF33B1 Q26795386-777D8933-BE26-4333-80F3-5B37A5E75BD9 Q26851409-F7BC4194-CDBF-4815-B18A-EA0EFB04B822 Q26851835-7C3A6F6F-A9A1-4B8C-AD7F-EAC429963BA5 Q26859859-3D58C7F8-6B23-433B-A55F-4D6704EF152A Q26995945-E43AD934-6A81-4498-9B5D-67A1A2776EBD Q28082059-5C448E2B-2FD9-4313-8D4B-CB94A1CCA84B Q28255756-F446FE74-2A17-480E-B647-AC8CA0A3B09E Q28294828-2D1ED49B-05EE-4206-864A-0CEFB8615376 Q30229530-C07CEE6D-4C88-4351-B8FD-C518F34E2F9C Q30252154-32AB1999-3A5B-445D-8DA9-CB9A35ED2100 Q30316981-6480FD39-1D7A-4064-8176-CD200657D33A Q30575525-C3308C0B-E13F-4E43-8B39-6B3EB00B162D Q30577908-B486B1D8-1E68-47C4-A60D-1C6B1AF22400 Q31127164-4812820C-517E-42C1-B5BE-C47B060463B2 Q33355598-0D6CE97C-DE3B-4ADB-BACF-615173E48146 Q33420665-98170F71-FE0D-475D-A576-C33781C81757 Q33463955-AA3ED720-603A-4CDE-BCC5-9B36CB1FA094 Q33598258-964A0D24-76F0-4FE0-9D07-3492E4EB7AE4 Q33771594-B97935C3-25F2-4707-9CDA-A144AB08A0C4 Q33797312-CCEF40D2-DB96-4EEF-8FB9-3237919A6701 Q34032245-C1255D5C-D235-47FC-82C5-207155BF8D15 Q34241426-4AD08553-2D7A-4C0C-BAA5-01CF19EA973F Q34260389-5D4CA2E4-33E7-4201-AD74-8C5E49B48AB3 Q34322517-16C6370C-B720-41E7-97A4-49ED969C436A Q34411373-6410E8AC-2258-4F6E-B279-D38B1412ACE6 Q34611463-BF5ABD7D-7D8A-473F-9445-9A057D8DB882 Q34629039-87BE7A63-708D-4A57-9CEF-51A7F6FDF404 Q34629572-2F14B01D-D273-480E-8F96-4B2161510B8D Q34649546-43E26E91-DE0E-4EBB-B4D1-0B0E1DA083BF Q34736772-6AC076AC-9C92-4DB8-8A2A-936C74BFCA97 Q34955629-7854B004-4D2D-4FDB-B09F-5F35F7749147 Q35000008-1FB6ADFE-8ED2-4DAA-BAFC-A9CDC090093F

P2860

Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube.

http://www.wikidata.org/entity/Q33964412

description

2003 nî lūn-bûn

@nan

2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Recurrent Clostridium difficil ...... stered via a nasogastric tube.

@ast

Recurrent Clostridium difficil ...... stered via a nasogastric tube.

@en

type

label

Recurrent Clostridium difficil ...... stered via a nasogastric tube.

@ast

Recurrent Clostridium difficil ...... stered via a nasogastric tube.

@en

prefLabel

Recurrent Clostridium difficil ...... stered via a nasogastric tube.

@ast

Recurrent Clostridium difficil ...... stered via a nasogastric tube.

@en

P1433

Q33964412-A5C9690F-EAB7-4A87-A68B-0F1516EAA0C6

P1476

Q33964412-DABE48C6-6FCB-4095-A8CF-38871C9D7DB2

P2093

Q33964412-0035E211-E3D3-4427-AFD3-A1CEBBCD399A

Q33964412-574C3D52-F156-43D5-846A-3BF3F3D69FE3

Q33964412-E0A23E04-2691-4AE1-876A-B73566007AE8

P2860

Q33964412-1F4C0445-7D70-4D59-9DD1-7329F050F712

Q33964412-248AE4FE-4916-4B97-9BE6-C5C294D9BB1E

Q33964412-91A2B1BF-EA11-4693-B856-42D9F37D7165

Q33964412-9FBE093B-8DE0-4B79-925D-ED1BBB4BCBF0

Q33964412-C1E75D14-0A4B-40F0-A6AA-42585ADD85EE

Q33964412-D50B713E-49E1-4599-BF6D-0126CA2B7817

P304

Q33964412-4C994D47-B4FA-467E-AFCA-534C08FAA24E

P31

Q33964412-953EA3CB-B057-40C8-8FCE-E374309FC0F1

P356

Q33964412-5DFC314E-B214-486A-BF5B-E253549EE86F

P407

Q33964412-6957DA96-5C34-453D-9505-573F33393EFC

P433

Q33964412-F7AD7EFB-A5D5-4F6B-A049-E91C0E95CA45

P478

Q33964412-D21722C2-9AC1-4890-B6E1-1563A936E2DB

P577

Q33964412-1457C233-F6F6-4D84-B3E4-323A124D3CD2

P5875

Q33964412-64084ABB-22E6-4CBE-AFE6-7E059DE2798B

P698

Q33964412-BEA13B02-7E8E-4286-BBA1-C529073547DD

P921

Q33964412-83C6DAC8-8F0D-4DE5-97A7-16C362C250CC

Q33964412-CA36B55C-F29C-42BF-B3A2-76991A6C5F85

P356

P1433

Clinical Infectious Diseases

P1476

Recurrent Clostridium difficil ...... stered via a nasogastric tube.

@en

P2093

Charles E Gessert

http://www.w3.org/2001/XMLSchema#string

Johan S Bakken

http://www.w3.org/2001/XMLSchema#string

Johannes Aas

http://www.w3.org/2001/XMLSchema#string

P2860

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles

Clostridium difficile colitis.

Clostridium difficile-associated diarrhea and colitis: clinical manifestations, diagnosis, and treatment.

Severe Clostridium difficile colitis.

Relapsing clostridium difficile enterocolitis cured by rectal infusion of homologous faeces.

P304

580-585

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/367657

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10892818

http://www.w3.org/2001/XMLSchema#string

P698

12594638

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile